Clinical Trial Update: Achieving Cannabis Cessation-Evaluating N-Acetylcysteine Treatment [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating N-acetylcysteine for cannabis dependence has completed, and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cannabis Dependence

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Medical University of South Carolina | Conditions: Cannabis Dependence | Phase 3 | Status: COMPLETED | Results posted: 2017-03-08